Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2001
11/01/2001WO2001036641A3 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO
11/01/2001WO2001036609A8 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
11/01/2001WO2001036608A8 Reversibly inactivated acidified plasmin
11/01/2001WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001WO2001029049A3 Imidazole derivatives as phosphodiesterase vii inhibitors
11/01/2001WO2001029025A3 Tyrosine kinase inhibitors
11/01/2001WO2001029015A3 Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
11/01/2001WO2001021620A3 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines
11/01/2001WO2001013924A8 Novel compositions for controlled release of a biologically active agent, and the preparation thereof
11/01/2001WO2001012233A3 Sustained release formulation of a peptide
11/01/2001WO2001010847A3 Novel integrin receptor antagonists
11/01/2001WO2001005937A3 Conversion of a watson-crick dna to a hoogsteen-paired duplex
11/01/2001US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001US20010036960 Carvedilol-lipophilic solutions
11/01/2001US20010036959 Carvedilol-hydrophilic solutions
11/01/2001US20010036950 Potassium channel openers
11/01/2001US20010036949 Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
11/01/2001US20010036948 Administering a vascular alkylating compound; prevention restenosis
11/01/2001US20010036946 Antiinflammatory agents
11/01/2001US20010036944 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
11/01/2001US20010036936 Compositions and methods for treating osteoporosis
11/01/2001US20010036921 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/01/2001US20010036898 Activating catalyst; reducing by-products
11/01/2001US20010036502 Oil composition
11/01/2001US20010036484 Improving blood flow circulation by administration of the combination of medicinal plants Panax ginseng and Ginkgo biloba or extracts thereof
11/01/2001US20010036454 Transfection of lung tissue
11/01/2001CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001CA2407449A1 Novel compounds
11/01/2001CA2407445A1 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo¬3,4-b|-pyridines as cyclin dependent kinase inhibitors
11/01/2001CA2407370A1 Heterocycles that are inhibitors of impdh enzyme
11/01/2001CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001CA2406725A1 Edg8 receptor, its preparation and use
11/01/2001CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001CA2406272A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001CA2406264A1 Protein phosphatases
11/01/2001CA2406067A1 Compositions comprising the combination of a bile acid and a fibrate for use in therapies for hyperlipidaemia-associated disorders
11/01/2001CA2405559A1 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use
11/01/2001CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001CA2402123A1 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
11/01/2001CA2372673A1 Cyclic amidine compounds
11/01/2001CA2365320A1 Novel heterocyclic compounds
10/2001
10/31/2001EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001EP1149583A2 Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
10/31/2001EP1149581A2 Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/31/2001EP1149113A1 Use of agonists or antagonists of mip-3a in therapy
10/31/2001EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001EP1149102A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
10/31/2001EP1149099A2 Imidazo[4,5-c]-pyridine-4-on-derivatives
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1149083A1 Morpholinobenzamide salts
10/31/2001EP1149074A1 Acetylenic sulfonamide thiol tace inhibitors
10/31/2001EP1149072A1 Sulfonamide hydroxamates
10/31/2001EP1149069A1 Phenylglycine derivatives
10/31/2001EP1149063A2 Ureido-thiobutyric acid derivatives as ppar-agonists
10/31/2001EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001EP1148881A1 USE OF PYRIDAZINO 4,5-$i(b)]INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS
10/31/2001EP1148873A2 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
10/31/2001EP0901466B1 Biphenylsulfonamide matrix metalloproteinase inhibitors
10/31/2001EP0876356B1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
10/31/2001EP0820455B1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
10/31/2001EP0811001B1 Benzothiazine dioxides as endothelin antagonists
10/31/2001EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/31/2001EP0743943B1 Pyridyl imidazole derivatives and processes for the preparation thereof
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001DE10021069A1 Substituiertes Pyrazolderivat Substituted pyrazole derivative
10/31/2001DE10019136A1 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung Polyamide nucleic acid derivatives, means, and methods for their preparation
10/31/2001CN1320125A Trizolopyridines for the treamtent of thrombosis disorders
10/31/2001CN1320116A Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
10/31/2001CN1320045A Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke
10/31/2001CN1320042A Seletive treatment of endothelial somatostatin receptors
10/31/2001CN1319594A Diazesuberane derivant or its salt
10/31/2001CN1319415A Pill medicine for treating cardio-cerebro vascular diseases
10/31/2001CN1319412A Medicine for treating tachy-arrhythmia
10/31/2001CN1319410A Ointment for curing piles
10/31/2001CN1319404A Medicine for treating coronary heart disease
10/31/2001CN1319396A Medicinal composition
10/31/2001CN1073988C Substituted N-heteroaroylguanidin, preparation, pharmaceutical application and medicine containg same
10/31/2001CN1073848C Ginkgo flavone internal ester extract and preparation process thereof
10/30/2001US6310226 Vitamin D analogues
10/30/2001US6310208 Serotonin receptor binding benzo[e]isoindoles and benzo[h]isoquinolines
10/30/2001US6310202 Nitric oxide carriers based on polyazamacrocycle complexes
10/30/2001US6310181 Adaptor protein FRS2 and related products and methods
10/30/2001US6310177 Compounds and methods for modulating tissue permeability
10/30/2001US6310094 Ready-to-use esmolol solution
10/30/2001US6310088 Treating condition associated with matrix metalloproteinases or mediated by tumor necrosis factor-alpha or enzymes involved in shedding l-selectin, cd23, tumor necrosis factor receptors, interleukin-6 receptors or interleukin-1 receptors
10/30/2001US6310079 Non-steroidal antiinflammatory agents
10/30/2001US6310075 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
10/30/2001US6310074 Substituted dimeric compounds
10/30/2001US6310068 Benzonitriles and benzofluorides
10/30/2001US6310063 Aminoalkyl substituted pyrrolo [3,2-E]pyridine and pyrollo [2,3-b]pyrimidine derivatives: modulators of CRF1 receptors
10/30/2001US6310059 Constrained fused ring derivatives of piperidine or piperazine linked to hydrophobic substituents which enhance calcium channel blocking activity; combinatorial libraries for drug screening
10/30/2001US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
10/30/2001CA2123101C Nitroxyalkylamide derivative
10/30/2001CA2052375C Parathyroid hormone derivatives
10/28/2001CA2345284A1 Blood pressure stabilization during hemodialysis
10/27/2001CA2345180A1 Methods of treating obesity using a neurotensin receptor ligand
10/25/2001WO2001079525A2 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001WO2001079480A1 Albumin fusion proteins
10/25/2001WO2001079444A2 Albumin fusion proteins
1 ... 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 ... 1595